James Kihara
Principal Accounting Officer, Acadia Pharmaceuticals.
Companies
- Acadia PharmaceuticalsPrincipal Accounting Officer Jul 2, 2020 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Acadia Pharmaceuticals ACAD13,088 shares2$256.7K at $19.61Jun 26, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 26, 2026Sold 11,421 shares at $26.08 of Acadia Pharmaceuticals2
- May 26, 2026Sold 5,401 shares at $21.18 of Acadia Pharmaceuticals3
- May 4, 2026Sold 1,332 shares at $21.79 of Acadia Pharmaceuticals4
- May 1, 2026Exercised options 2,596 shares of Acadia Pharmaceuticals4
- Apr 7, 2026Sold 1,030 shares at $22.20 of Acadia Pharmaceuticals5
- Apr 5, 2026Exercised options 2,010 shares of Acadia Pharmaceuticals5
- Mar 26, 2026Sold 12 shares at $21.73 of Acadia Pharmaceuticals6
- Mar 26, 2026Sold 1,097 shares at $21.65 of Acadia Pharmaceuticals6
- Mar 25, 2026Exercised options 2,142 shares of Acadia Pharmaceuticals6
- Mar 25, 2026Sold 833 shares at $21.47 of Acadia Pharmaceuticals6
- Mar 24, 2026Exercised options 1,627 shares of Acadia Pharmaceuticals6
- Nov 18, 2025Sold 4,084 shares at $23.69 of Acadia Pharmaceuticals7
- Nov 17, 2025Exercised options 3,966 shares of Acadia Pharmaceuticals7
- Nov 17, 2025Exercised options 3,966 shares of Acadia Pharmaceuticals7
- May 16, 2025Sold 2,000 shares at $20.00 of Acadia Pharmaceuticals8
- May 16, 2025Sold 2,000 shares at $25.00 of Acadia Pharmaceuticals8
- May 2, 2025Sold 1,327 shares at $14.60 of Acadia Pharmaceuticals9
- May 1, 2025Exercised options 2,596 shares of Acadia Pharmaceuticals9
- Apr 8, 2025Sold 1,028 shares at $14.82 of Acadia Pharmaceuticals10
- Apr 5, 2025Exercised options 2,010 shares of Acadia Pharmaceuticals10
- Mar 26, 2025Sold 1,095 shares at $17.05 of Acadia Pharmaceuticals11
- Mar 25, 2025Exercised options 2,142 shares of Acadia Pharmaceuticals11
- Feb 24, 2025Sold 475 shares at $19.96 of Acadia Pharmaceuticals12
- Feb 23, 2025Exercised options 840 shares of Acadia Pharmaceuticals12
- Nov 19, 2024Sold 4,073 shares at $16.81 of Acadia Pharmaceuticals13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed May 27, 2026
- 4SEC EDGARForm 4 filed May 5, 2026
- 5SEC EDGARForm 4 filed Apr 7, 2026
- 6SEC EDGARForm 4 filed Mar 26, 2026
- 7SEC EDGARForm 4 filed Nov 19, 2025
- 8SEC EDGARForm 4 filed May 19, 2025
- 9SEC EDGARForm 4 filed May 2, 2025
- 10SEC EDGARForm 4 filed Apr 8, 2025
- 11SEC EDGARForm 4 filed Mar 26, 2025
- 12SEC EDGARForm 4 filed Feb 25, 2025
- 13SEC EDGARForm 4 filed Nov 19, 2024